Developing Wolbachia-based disease interventions for an extreme environment
PLOS Pathogens · 2023
DOI: 10.1371/journal.ppat.1011117 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Perran A Ross und 17 weiteren Autor:innen. Beteiligte Einrichtung: Pest and Environmental Adaptation Research Group, Bio21 Institute and the School of Biosciences, University of Melbourne, Parkville, Victoria, Austra…. Hauptthemen laut MEDLINE: Wolbachia, Aedes, Dengue. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KACST-CSIRO co-investment, CSIRO, National Health and Medical Research Council.
Abstract (Originalsprache)
Aedes aegypti mosquitoes carrying self-spreading, virus-blocking Wolbachia bacteria are being deployed to suppress dengue transmission. However, there are challenges in applying this technology in extreme environments. We introduced two Wolbachia strains into Ae . aegypti from Saudi Arabia for a release program in the hot coastal city of Jeddah. Wolbachia reduced infection and dissemination of dengue virus (DENV2) in Saudi Arabian mosquitoes and showed complete maternal transmission and cytoplasmic incompatibility. Wolbachia reduced egg hatch under a range of environmental conditions, with the Wolbachia strains showing differential thermal stability. Wolbachia effects were similar across mosquito genetic backgrounds but we found evidence of local adaptation, with Saudi Arabian mosquitoes having lower egg viability but higher adult desiccation tolerance than Australian mosquitoes. Genetic background effects will influence Wolbachia invasion dynamics, reinforcing the need to use local genotypes for mosquito release programs, particularly in extreme environments like Jeddah. Our comprehensive characterization of Wolbachia strains provides a foundation for Wolbachia -based disease interventions in harsh climates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pest and Environmental Adaptation Research Group, Bio21 Institute and the School of Biosciences, University of Melbourne, Parkville, Victoria, Australia.
- CSIRO Health and Biosecurity, Australian Centre for Disease Preparedness (ACDP), Geelong, Victoria, Australia.
- Department of Genetics, University of Cambridge, Cambridge, United Kingdom.
- Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
ORCID-Profile: Perran A Ross
Förderung
- KACST-CSIRO co-investment
- CSIRO
- National Health and Medical Research Council
Zitieren
APA
Ross, P. A., Elfekih, S., Collier, S., Klein, M. J., Lee, S. S., Dunn, M., Jackson, S., Zhang, Y., Axford, J. K., Gu, X., Home, J. L., Nassar, M. S., Paradkar, P. N., Tawfik, E. A., Jiggins, F. M., Almalik, A. M., Al-Fageeh, M. B., & Hoffmann, A. A. (2023). Developing Wolbachia-based disease interventions for an extreme environment. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011117
Vancouver
Ross PA, Elfekih S, Collier S, Klein MJ, Lee SS, Dunn M, et al. Developing Wolbachia-based disease interventions for an extreme environment. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011117
BibTeX
@article{Ross2023,
author = {Ross, Perran A and Elfekih, Samia and Collier, Sophie and Klein, Melissa J and Lee, Su Shyan and Dunn, Michael and Jackson, Sarah and Zhang, Yexin and Axford, Jason K and Gu, Xinyue and Home, Jessica L and Nassar, Majed S and Paradkar, Prasad N and Tawfik, Essam A and Jiggins, Francis M and Almalik, Abdulaziz M and Al-Fageeh, Mohamed B and Hoffmann, Ary A},
title = {Developing Wolbachia-based disease interventions for an extreme environment},
journal = {PLOS Pathogens},
year = {2023},
doi = {10.1371/journal.ppat.1011117}
}
EUVIMED